Navigation Links
FDA chief takes decision without two senior officials’ opinion

In a crucial decision taken to delay action on Barr Pharmaceuticals Inc.’s 'morning-after' contraceptive the FDA chief did not take two senior officials opinion.// The FDA is in thick smoke as it has been sued by the non-profit Center for Reproductive Rights saying science was influenced by politics.

Director of the FDA’s Center for Drug Evaluation and Research, Dr. Steven Galson, admitted that he wanted to approve the drug. Still, in Galson’s words, “then Acting FDA Commissioner Lester Crawford told me that he was concerned about where we were heading because he knew that I was heading towards this recommendation, and he told me that he was going to make the decision on what to do with the application.”

A set of pills that can prevent pregnancy if taken within 72 hours of sexual intercourse is what the drug is all about.

The acting chief then, Crawford was confirmed as permanent FDA commissioner in July 2005. Thereafter this delay was announced.

This is the bone of contention and can land him in trouble.

Page: 1

Related medicine news :

1. EU medical chief says Europe ready for bird flu
2. Making Budhia run 65 km absolutely cruel,says Infosys chief
3. A&E departments To Be Shut Down warns NHS chief
4. NHS acting chief’s intervie
5. Mittal tightens grip on steel making giant, to be its chief
6. India takes on foot-and-mouth disease by vaccinating animals
7. Roller coaster takes brain for a big ride!!
8. Children! Protecting them from medical mistakes
9. Men who takes risk is unlikely to impress women
10. Research on HIV takes new direction
11. Anorexia nervosa takes its toll on life!!
Post Your Comments:

(Date:12/1/2015)... ... 01, 2015 , ... Physicians’ Education Resource®, LLC (PER®) ... announced that the first annual School of Gastrointestinal Oncology™ (SOGO™) will be held ... treatment of gastrointestinal cancers are undergoing transformational change, providing oncologists with powerful new ...
(Date:12/1/2015)... ... December 01, 2015 , ... Speech and ... believe that with innovative technologies and under the right circumstances, these practices can ... benefit of a dual-approach to his or her therapeutic sessions, as well as ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... the 7th Annual 2015 Golden Bridge Business Awards under the New Products and ... zero capex web based sample management software that helps labs organize ...
(Date:12/1/2015)... ... December 01, 2015 , ... The importance of volumetric ... the focus of numerous abstracts accepted for presentation here, at the 101st Annual ... abstracts highlight the use of Volpara Solutions’ quantitative breast imaging software tools for ...
(Date:12/1/2015)... ... December 01, 2015 , ... SAN FRANCISCO, Calif. ... that the organization has awarded Education and Developmental Therapies (EDT), an Applied Behavior ... award celebrates exceptional special needs providers that excel in synthesizing the areas of ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... Russia has always been a country of choice for ... Europe in 2015 were tested in phase II-III ... has always been a country of choice for global multi-center phase ... in 2015 were tested in phase II-III clinical trials ... always been a country of choice for global multi-center phase III clinical ...
(Date:12/1/2015)... ANGELES , Dec. 1, 2015 CytRx ... development company specializing in oncology, today announced that it ... the company,s pivotal global Phase 3 clinical trial of ... (STS). Enrollment was originally estimated to be completed in Q1 ... being conducted under a Special Protocol Assessment from the ...
(Date:12/1/2015)... , Dec. 1, 2015  The migration to ... develop shared care plans that help patients stay ... plans will be digitally enabled, incorporate care guidelines ... and desires. They will also allow all stakeholders ... health journey is optimal. That is the vision, ...
Breaking Medicine Technology: